| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +303K | 100% | $1.27 | +$385K |
| Sells | 0 | ||||
| Net | +3 | +303K | 100% | +$385K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jeremy M. Sclar | 10%+ Owner | $10.6M | Jul 31, 2024 | ||
| Michael S. Gordon | 10%+ Owner | $3.1M | +$117K | +3.91% | Sep 16, 2024 |
| Title 19 Promis | 10%+ Owner | $2.59M | Jul 31, 2024 | ||
| Madge Shafmaster | Director | $271K | +$256K | +1686% | Oct 3, 2024 |
| Gail M. Farfel | Chief Executive Officer, Director | $256K | Aug 23, 2023 | ||
| Patrick D. Kirwin | Director | $124K | +$12.5K | +11.2% | Oct 3, 2024 |
| Gavin T. Malenfant | Chief Operating Officer, Director | $12.3K | Oct 26, 2023 | ||
| Richard J. Gregory | Director | Jul 7, 2022 | |||
| Daniel E. Geffken | Chief Financial Officer | Oct 26, 2023 | |||
| Johanne Kaplan | Chief Development Officer | Nov 18, 2024 | |||
| William W. Wyman | Director | Oct 3, 2024 | |||
| Neil Cashman | Chief Scientific Officer, Director | Nov 18, 2024 | |||
| Max A. Milbury | Principal Accounting Officer | Nov 18, 2024 | |||
| Eugene Williams | Director | Oct 3, 2024 | |||
| Neil Warma | Chief Executive Officer | Oct 8, 2024 | |||
| Larry Douglas Altstiel | Chief Medical Officer | Nov 18, 2024 | |||
| Josh Mandel-Brehm | Director | Oct 3, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|